Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q3 2024 Earnings Call Transcript

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q3 2024 Earnings Call Transcript November 13, 2024

Operator: Hello and welcome to the Adaptimmune Therapeutics Third Quarter 2024 Results Conference Call. As a reminder, all participants are in listen-only mode, and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. [Operator Instructions] I will now turn the call over to Dan Od-Cohen, Investor Relations for Adaptimmune. Dan, please go ahead.

Dan...